0 results

    Digital Medicine

    We work with founders to build companies leveraging AI, machine learning and data analytics to transform healthcare and medicine.

    Our approach is evidence-based, rooted in rigorous scientific research and clinical validation and builds on Sofinnova's 50 years of experience in the life sciences sector.

    2023Sofinnova Digital Medicine I$200 million
    • Close: 2023

      Fund: Sofinnova Digital Medicine I

      AMT: $200 million

    "We bring our experience in biological innovation coupled with powerful computing and AI capabilities to build deeply technical companies to product-market fit. This is what makes our approach unique."

    "We designed this strategy to help founders leverage our knowledge of a highly-regulated and complex healthcare industry while drawing on the strengths of tech-industry approaches like rapid product iteration and swift commercialization."


    Fund iteration
    Deal lead